Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Clinical Trial of Celecoxib /OR Nsaid/ for Prevention of Spor-261995015
Strang Cancer Prevention Cent
Search grants from Strang Cancer Prevention Cent
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Optimizing Trauma Systems Planning Using Interactive Web-Based Mapping
Early Exposure to Stimulants as a Risk Factor for Substance Abuse
Brain Gamma and Positron Labeled Phentermine Analogs
Memorandum of Agreement (MOA) between the National Science foundation , Office of Polar Programs and the Office of Naval Research.
The Deep Lens Survey
Recently added grants:
Targeting Pannexin 1 as a Novel Mechanism for Arrhythmia and Fibrosis in Duchenne Cardiomyopathy
Examining the Stress Processes Relating Ethnicity and Sex to Substance Misuse and Services Outcomes (ESPRESSO)
The ontogeny and function of CD8 T cells in lung cancer
Development of an artificial intelligence-driven, imaging-based platform for pretreatment identification of extranodal extension in head and neck cancer
The glucocorticoid receptor as a mechanism of top-down control of cue-motivated behavior
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN995015-001
Application #
6994841
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2004
Total Cost
Indirect Cost
Institution
Name
Strang Cancer Prevention Cent
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CN
Phase II Clinical Trial of Celecoxib /OR Nsaid/ for Prevention of Spor-261995015
/ Strang Cancer Prevention Cent
NIH 2004
N01 CN
Phase II Clinical Trial of Celecoxib /OR Nsaid/ for Prevention of Spor-261995015
/ Strang Cancer Prevention Cent
Comments
Be the first to comment on this grant